Velo3D: A Long-Term Owner's Perspective

Customer concentration risk, while improved from the early years, remains elevated. The top three / top five customers were heavily concentrated in 2021, with the top three accounting for about 62% of revenue in 2021, about 46.4% in 2022, about 24.5% in 2023, and still about 33.2% in 2025. The 2025 customer-concentration table shows single customers accounting for 11.2%, 10.6%, and 11.4% of revenue, with some of those customers representing 34.0% and 16.2% of accounts receivable. This shows that while the company is broadening its customer base, it has not yet escaped the pattern where "a big order determines the quality of the year."

The supply chain is not entirely secure either. In its 2025 annual report, the company stated plainly that, although most equipment and materials can be sourced from multiple suppliers, certain items still depend on limited-source suppliers. If those suppliers fail or raise prices, the company may have to spend significant time and money finding alternatives.

This business is "understandable at a high level" but "not simple at the cash-flow level." You can understand it as "selling high-complexity metal printing capability plus accompanying software/services," yet it is hard to predict its 5–10 year cash-return path as cleanly as you can for Coca-Cola, Moody's, or Automatic Data Processing. If the stock market closed for five years, I would not want to hold this as a core long-term position at the current stage.

The Industry and Competitive Landscape

Metal additive manufacturing is not itself a declining industry. Demand comes from long-term trends: lightweighting complex components, shortening delivery cycles, increasing design freedom, and advancing the localization and resilience of defense supply chains. Grand View Research expects the metal additive manufacturing equipment market to keep growing from 2025 to 2033, with aerospace and defense end-applications growing faster; EOS likewise frames "shorter lead times, manufacturing closer to the point of need, and improved mission readiness" in defense and critical-spares settings as its core value proposition.

But a fact that matters just as much: the industry's economics are not great. 3D Systems posted full-year 2025 revenue of $386.9 million, down 12% from 2024; Stratasys posted full-year 2025 revenue of $551.1 million, below 2024's $572.5 million. Although their operating and cash-flow quality is clearly better than VELO's, the industry as a whole does not look like a "winner-take-all, rapidly expanding profit pool." 3D Systems management has even said outright that additive manufacturing is only just emerging from "years of malaise."

So this industry looks more like the following: the long-term demand direction is right, but the path to commercial realization is long, cyclicality and project-level volatility are pronounced, competing technology routes are numerous, and the barriers of capital spending and customer qualification are not low. This is not the classic "a great company in a bad industry" situation. It is more like "a promising market in which most participants have not yet built a solid economic moat."

On competitors, the most frequently compared public names are 3D Systems and Stratasys; at the more direct level of metal AM technology, EOS, Nikon SLM Solutions, and others also possess mature industrial capability and access to defense/aerospace customers. EOS explicitly markets "reduced supports, finer detail, and serving defense and high-temperature-alloy applications," which shows that Velo3D's pitch of "complex geometries, reduced supports, support for mission-critical parts" is not an entirely unique capability narrative.

My read on the industry: the demand is real, the industry's attractiveness is average, and the profit structure is not stable enough. From a value-investing standpoint, this is not an industry shape I favor.

How Wide Is the Moat

Brand advantage. Velo3D has some industry recognition in high-complexity metal-part printing and in aerospace and defense case studies, but it is far from a mainstream or oligopoly brand. Its brand is more a matter of technical-circle awareness than a consumer brand that naturally converts into stable, high ROIC.

Cost advantage. Not visible for now. Years of negative gross margin and frequent inventory write-downs are themselves evidence that no cost moat has been built. A roughly $7 million obsolete-inventory write-down in Q4 2025 weighed on gross margin, and in 2023 the company took an inventory-valuation reserve of about $27.10 million. Truly cost-advantaged industrial companies rarely show this kind of margin volatility over so long a stretch.

Scale advantage. Not yet. Full-year 2025 revenue was just $46 million, far smaller than the main public comparables, and the company's own plan for up to about 400 production systems over a 10-year expansion explicitly depends on additional financing. A scale moat is not today's reality; it is management's vision.

Network effects. Almost no obvious network effects. A larger installed base could bring more manufacturing data and service opportunities, but that remains at the vision stage rather than a reality reflected in the profit structure. In its 2025 letter to shareholders, management said it hopes to develop manufacturing data into a new, durable revenue stream in the future, but that is a forward-looking goal, not an existing moat.

Switching costs. Some, but not especially strong. Once aerospace and defense customers complete process validation, material validation, and part validation, switching costs do rise; the company disclosed that, as of year-end 2025, more than 50% of customers own multiple Sapphire systems, which indicates some repeat purchasing and path dependence. At the same time, the top-three customer list changes noticeably each year, showing that such switching costs are not yet enough to produce a stable, predictable lock-in effect.

Patents and technology barriers. Yes, but they should still be discounted. The company website emphasizes its "Patented Laser Powder Bed Fusion," but competitors are likewise pushing support reduction, thermal management, and complex metal-part printing. In other words, a technology barrier does exist, but a technology barrier does not equal an economic moat.

Pricing power and resilience to cycles. No strong evidence right now. Years of low and volatile gross margins suggest that, in the face of inflation, shifting supply and demand, and project delays, the company is more a price taker than a strong supplier able to pass through price increases smoothly. In Q4 2025, gross margin swung from -3.5% in the year-ago quarter to -73.6%, driven by inventory write-downs and delays from a government shutdown; that kind of swing is the opposite of a "strong moat."

It may hold a technology trench that has not yet been fully commercialized, but it is a long way from a "wide moat." I would rather define it as "possibly possessing a technology edge, but with insufficient evidence of an economic moat."

Management and Capital Allocation

Is Management Trustworthy

Current CEO Arun Jeldi took office on December 24, 2024, and has also served as Chairman since April 2025; the 2026 proxy statement shows he controls about 48.6% of outstanding common shares. Of the board's five members, three are deemed independent; the CEO and Chairman roles are not separated, and Jason Lloyd serves as lead independent director.

This creates a classic "double-edged sword" structure. On one hand, the CEO's large stake theoretically aligns him with shareholders; on the other, control is highly concentrated, leaving minority shareholders with limited ability to check capital allocation and dilutive financing. For a long-term investor, this is not inherently bad, but it demands higher governance transparency to offset control risk.

From the angle of "tying himself to shareholders," the CEO purchased and converted $5 million of company notes in March 2026, doing so at a conversion price above the then-current share price, which is a positive signal. Director Kenneth Thieneman also converted $10 million of notes into equity.

But the other side is equally factual. Management and finance leadership have turned over fairly often in recent years: a new CFO was appointed in April 2024, and another new CFO in March 2026. For a company undergoing complex debt restructuring, a revenue-model transition, and internal-control remediation, finance-team stability is inherently very important. Frequent CFO changes erode outside investors' confidence in the maturity of the financial system.

Is Capital Allocation Rational

Over the past three years, the core of capital allocation has not been "growth in intrinsic value per share," but "raise money, stay alive, cut leverage, and sustain expansion." In 2023, the company issued $70 million of senior secured convertible notes with a 6% coupon, maturing in 2026, with a principal repurchase price of 115%; in 2025 and 2026, it carried out debt exchanges, private placements, debt-to-equity conversions, and direct offerings. After Q1 2026, the company completed a direct offering of about $50 million; before that, it had completed a private placement of about $30 million.

In both the 2025 letter to shareholders and the 2026 earnings press release, management stated clearly that the company plans to expand RPS capacity and expects 2026 capital expenditure of $40 million to $50 million, "subject to securing adequate financing." It also indicated it may continue to raise capital and consider selective acquisitions.

This shows management's capital-allocation logic is not entirely irrational, but rather substitutes "betting on expansion" for "first proving single-machine economics and cash returns." If the company had already proven a stable return profile, this approach would be understandable; but while the company still has negative Owner Earnings and material internal-control weaknesses, the expand–finance–expand path is not friendly to conservative investors.

The 2025 annual report also disclosed that internal controls were not effective as of year-end 2025, owing to a material weakness in accounting for share-based compensation and a control deficiency related to depreciation of operating-lease equipment; the 2025 financials also adjusted and restated items such as 2024 share-based compensation expense. Although the company calls these adjustments immaterial to prior periods, they remain a red flag that a value investor should take seriously.

My overall impression of management right now: there is equity alignment, there is aggressiveness, and they are actively repairing the balance sheet; but financial controls, capital discipline, and the long-term capital-allocation record are all still far from excellent.

Financial Quality and Owner Earnings

Key Financial Metrics

The table below is compiled from the 2021–2025 annual reports, the 2024/2025/2026 earnings press releases, and the Q1 2026 financial pages. Note that the 2025 1-for-15 reverse stock split makes historical share counts not fully comparable; the table therefore focuses on revenue, profit, cash flow, and balance-sheet quality, rather than making fine comparisons of earlier share counts.

These numbers make three things clear. First, revenue is extremely volatile: 2022 revenue was nearly triple 2021's, but 2023 stalled, 2024 fell sharply back to $41 million, and 2025 recovered only modestly to $46 million; not until Q1 2026 did a 48% year-over-year improvement appear. Second, profit quality is poor: 2022 showed accounting net income of $10.02 million, yet operating cash flow that year was a net outflow of $124 million. That "profit" was driven mainly by non-cash items such as fair-value changes, not genuinely distributable earnings. Third, cash flow has stayed negative: even though year-end 2025 cash rebounded sharply, that essentially came from financing rather than self-generated funds.

On the surface, the 2025 balance sheet looks far healthier than 2024's: year-end cash of $39.013 million, inventory down to $27.083 million, current assets of $80.12 million, current liabilities of $33.802 million, and shareholders' equity of $38.156 million. In Q1 2026, cash fell again to about $17.187 million (including restricted cash), showing the business itself still burns a great deal of cash; the April 2026 $50 million offering only temporarily eased that.

Inventory and working capital have long been a cash-flow black hole. Inventory was $22.479 million in 2021, surged to $71.202 million in 2022, was still $60.816 million in 2023, $49.953 million in 2024, and fell to $27.083 million in 2025 — but that decline came alongside large write-downs: in 2023 the company disclosed an inventory-valuation reserve of about $27.10 million, and in Q4 2025 it took an obsolete-inventory write-down of about $7 million. For an industrial-equipment company, this shows that demand forecasting, delivery timing, and inventory management have long been unstable.

Accounting risk cannot be ignored. In 2025 the company disclosed a restatement of 2024 share-based compensation expense and related income-tax items; management also acknowledged that internal controls were not effective as of year-end 2025, with material weaknesses involving share-based compensation accounting and the control environment itself. Even if the company deems these corrections immaterial to historical periods, for a conservative value investor this is already enough to lower the trust score.

The company's core financial picture over the past few years is not "the more it grows, the more it earns," but rather "growth requires capital, capital is exchanged for the next round of growth, and cash flow stays under pressure throughout." That is far from the classic value-investing favorite of "high returns, low reinvestment, cash emerging naturally."

Owner Earnings Analysis

I try to use a Buffett-style "Owner Earnings" approach here, but I must say up front: for a company like Velo3D, Owner Earnings is not "slightly below net income" but "clearly negative." So it is better used to judge "how far the company is from truly making money" than to apply a steady-state multiple as one would for a mature company.

Conservative estimation basis. Owner Earnings ≈ net income

• non-cash expenses (depreciation and amortization, share-based compensation, some non-cash fair-value changes, etc.) − maintenance capital expenditure − additional working capital required

2025. The company disclosed a 2025 net loss of about $71.40 million; operating cash flow was a net outflow of about $27.30 million; cash spent on purchasing fixed assets was about $2.70 million. Looking purely at the cash basis, rough 2025 Owner Earnings can be approximated at around -$30 million. That figure already takes a fairly lenient view of maintenance capex, since it does not additionally deduct the expansion / process-upgrade investment needed to keep competing.

Q1 2026. Q1 2026 net loss was about $7 million, operating cash flow was a net outflow of about $17.98 million, and capital expenditure was about $940,000. A simple annualization leaves current Owner Earnings still firmly negative. Management's 2026 capex guidance runs as high as $40 million to $50 million, noted again as "subject to adequate financing"; this means that even if EBITDA turns positive, free cash flow truly belonging to shareholders may not turn positive in step.

Key judgments.

• Is the profit genuine cash profit, or accounting profit? Mostly not cash profit in recent years. The 2022 case of positive GAAP net income alongside deeply negative operating cash flow is a textbook counterexample.

• Does growth require heavy capital investment? Yes. The 2026 capex guidance alone makes that clear.

• Does the company earn more as it grows, or run short of cash as it grows? So far, closer to the latter.

• Is free cash flow over the long run higher than, lower than, or close to net income? Over the long run clearly lower than net income, with even the 2022 divergence of "positive net income, sharply negative cash flow."

• What multiple of Owner Earnings does the current valuation represent? Meaningless. On a conservative basis Owner Earnings is negative and cannot be explained with a mature-company multiple.

For a long-term business owner, VELO has not yet cleared the most important threshold: proving it can stably generate positive Owner Earnings without continuously diluting shareholders.

Intrinsic Value, Valuation, and Margin of Safety

Valuation Premises

First, separate "facts, assumptions, inferences, and opinions."

The current price is about $22.13; the quote source shows market cap of about $554 million. 2025 revenue was about $46 million, 2026 management guidance is for revenue of $60 million to $70 million, with EBITDA turning positive in the second half. 2025 operating cash flow was about -$27.30 million, and 2026 capex guidance is $40 million to $50 million.

Dividing the current quote directly by 2025 sales, VELO trades at a price-to-sales ratio of about 12x; even using the 2026 guidance midpoint of $65 million, the forward P/S is about 8.5x. Accounting for the higher share count after the April 2026 offering, the actual P/S could be higher still.

Year-end 2025 shareholders' equity was about $38.156 million, so on the quote-source basis the current price-to-book is roughly 14.5x. With the company's Owner Earnings negative, mainstream mature-company metrics such as P/E, EV/EBITDA, and P/FCF have essentially no explanatory power.

Discounted Owner Earnings Method

Because current Owner Earnings is negative, I use a conservative rebuild approach of "revenue growth first, then margin improvement, then discounting," rather than mechanically extrapolating the 2025 negative figure. The following are assumptions, not facts.

Under those assumptions, the per-share intrinsic value I arrive at is roughly:

• Conservative scenario: $0 to $5 per share.

• Neutral scenario: $6 to $10 per share.

• Optimistic scenario: $12 to $18 per share.

The intuition behind this result is also clear: to support a share price above $22 today, the company must not only deliver on management's 2026 guidance, but also sustain high growth for several years, lift gross and operating margins into a range far above their historical levels, and keep follow-on dilution under control. For a company that has not yet proven positive Owner Earnings, that is a demanding script.

Relative Valuation Method

Here I pick two more appropriate public comparables: 3D Systems and Stratasys. They are not exact peers, but both are far more mature industrial additive-manufacturing platforms.

3D Systems currently has a market cap of about $556 million, 2025 revenue of about $386.9 million, Q1 2026 cash of about $86.50 million, and debt principal of about $95.90 million; a rough EV/Sales of about 1.5x. Stratasys currently has a market cap of about $740 million, 2025 revenue of about $551.1 million, year-end cash, equivalents, and short-term deposits of about $244.5 million, and no debt; a rough EV/Sales of about 0.9x. By contrast, VELO, on the quote-source basis, trades at about 12x P/S against 2025 sales, and about 8.5x P/S against the 2026 revenue midpoint.

Even allowing for VELO's smaller revenue base and greater operating leverage, it is hard to fully explain away that gap with a "growth premium." The usual precondition for enjoying a high multiple is having already proven stronger business-model quality, which is exactly what VELO lacks today. It has no stable positive cash flow, no steady-state ROIC, no meaningful network effects, and no validated strong pricing power.

Asset Value and Liquidation Value Method

At year-end 2025, Velo3D had about $39.01 million in cash, about $6.26 million in accounts receivable, about $27.08 million in inventory, about $13.09 million in net fixed assets, about $1.63 million in net operating-lease equipment, about $67.19 million in total liabilities, and about $38.16 million in shareholders' equity.

From a liquidation standpoint, both inventory and equipment carry significant specificity, and given the company's history of repeated inventory write-downs, book value may not equal realizable value. Even applying a relatively friendly liquidation discount, the equity liquidation value is most likely far below the current market cap. In other words, this stock has no "asset floor" to protect your downside. If follow-on financing falls short, order delivery stalls, or gross margin turns negative again, equity value would compress rapidly like an option, rather than rest on the relatively solid net-asset support of an asset-heavy company.

Price Range Judgment

Combining the three methods, I offer the following ranges.

For a balanced, conservative investor, I would not participate at the current price. Even if you are very bullish on the technology, this looks more like prepaying a high price for a "business model that might mature in the future."

Is the Margin of Safety Adequate

The conclusion is very clear: inadequate.

The most fragile assumptions in the valuation are these three holding simultaneously: First, sustained high revenue growth from 2026 to 2028; Second, gross and operating margins improving durably rather than being driven by a one-off mix or a single project; Third, expansion financing not coming at the cost of significant dilution of common shareholders.

If any one of these three assumptions breaks, the current valuation could lose its support. In particular, the company has explicitly tied 2026 capex of $40 million to $50 million to financing conditions, which means "growth below expectations" and "financing cost / dilution above expectations" could well occur at the same time.

Risks, the Bear Case, and Comparison with Other Opportunities

Key Risks and the Strongest Bear Case

Competition risk. Velo3D is not the only player able to provide industrial-grade solutions for high-complexity metal parts. Companies such as EOS likewise emphasize reduced supports, finer detail, and serving defense and high-temperature, high-requirement settings; in the public market, 3D Systems and Stratasys, while not identically positioned, both show that industry competition is not a blank field.

Technology-substitution and commercialization risk. A technology lead that cannot translate into sustained customer repurchase and high gross margin will not automatically become shareholder return. Velo3D's revenue volatility, negative gross margins, and frequent inventory write-downs over the past few years are themselves evidence that the conversion from "technology story" to "economic return" has not been completed.

Financial and financing risk. Both the 2024 and 2025 annual reports contained going-concern-related material-uncertainty language; even though financing at year-end 2025 and in April 2026 eased liquidity, the company still states clearly that it needs additional financing to support expansion and seize opportunities. For common shareholders, this means a fairly high probability of facing dilution or more complex capital-structure arrangements in the future.

Order and customer-concentration risk. The top three customers accounted for about 33.2% of 2025 revenue, and the company explicitly says that, having entered defense and government markets, opportunities may concentrate further into a few projects, prime contractors, qualification paths, and programs. This type of revenue quality tends to be more "fat-tailed": very good in good times, and very bad in bad ones.

Supply-chain and inventory risk. Certain key items depend on limited-source suppliers; the company also took sizable inventory write-downs in 2023 and 2025, showing that demand judgment, product iteration, and delivery organization still convert technology risk into financial risk.

Accounting and governance risk. Internal controls were ineffective at year-end 2025, share-based-compensation accounting had a material weakness, and related historical data was restated; for a value investor, this is a serious warning.

The strongest bear case. If I were to stand on the short side, the strongest logic is this: Velo3D is not "an undervalued good company," but "an overvalued, high-risk industrial-technology story." The reasoning is that it has yet to prove positive Owner Earnings, must support growth with outside capital, faces a competitive field that is not empty, and already trades far above mature peers' revenue multiples; if any one of high growth, margin recovery, or financing conditions fails, the common stock could suffer permanent capital loss.

Which facts would overturn my cautious view. If the following combination appears across several consecutive quarters, I would be willing to revise my view upward:

• Gross margin stably holding above 30%, rather than improving by chance in a single quarter;

• Operating cash flow turning positive and no longer relying on frequent financing transfusions;

• RPS / service revenue rising meaningfully as a share, improving revenue predictability;

• Each additional unit of revenue after expansion bringing higher incremental gross margin and cash flow, rather than a larger funding gap;

• Internal-control remediation completed, with stable audit and financial-disclosure quality.

Comparison with Other Opportunities

Versus more mature competitors in the same field. 3D Systems and Stratasys are not perfect companies, but in revenue scale, balance sheet, cash reserves, and operating maturity they are all clearly stronger than VELO; even so, their valuation multiples are far lower than VELO's. In other words, the market is giving VELO not a "distress discount" but a "high-growth premium," which does not match its actual financial quality.

Versus a broad-market index. SPY currently trades at about $759.57, representing diversified exposure to a basket of mature, profitable companies. For a balanced, conservative investor with a holding period of 10 years or more, VELO does not show a certainty advantage sufficient to clearly beat a broad index; you take on higher business, financing, and governance risk without a matching margin of safety.

Versus risk-free or high-grade bond yields. Even without citing a specific Treasury yield, the logic holds: when a company has yet to generate stable positive Owner Earnings, yet its stock valuation asks investors to prepay a premium for distant success, it must offer a certainty-adjusted expected return far above that of risk-free assets to be worth allocating to. Velo3D clearly cannot do that today.

If I could hold only five assets, would it qualify for the portfolio? My answer is: no. At least at the current price, no.

Investment Checklist and Final Judgment

Investment Checklist

Final Investment Conclusion

【Final Rating】 Avoid

【One-Sentence Investment Thesis】 Velo3D may have technology worthy of respect, but it is still not a good business that has proven it can stably create cash for long-term shareholders, while the price the market gives it has already priced in many assumptions of success ahead of time.

【Core Bull Case】 The metal additive manufacturing the company operates in has real long-term demand in aerospace, defense, and high-complexity industrial parts. The company won several defense- and aerospace-related contracts/partnerships in 2025–2026, and its order backlog reached $31 million at year-end 2025, showing the product is not going unwanted. Q1 2026 revenue grew 48% year over year and gross margin turned positive to 17.2%, showing operating leverage is not entirely absent. The CEO has a high stake and has put real money into debt-to-equity conversion, indicating at least some alignment of interests on governance.

【Core Bear Case】 The company has still not proven stable positive Owner Earnings; operating cash flow was negative across 2021–2025, and Q1 2026 still burned a great deal of cash. Growth depends on continuous financing, with 2026 capex guidance as high as $40 million to $50 million and explicitly constrained by the availability of financing. The technology moat lacks delivered economic evidence, competitors are not few, and the industry's overall profitability is weak. The current valuation is markedly expensive relative to mature peers, while the company itself remains at a stage of high uncertainty. Internal controls have material weaknesses, and the historical financial statements still carry share-based-compensation-related adjustments, which raises the governance discount.

【Key Assumptions】 For the investment to work, the following conditions must hold: The company can deliver on its 2026 guidance and continue high growth after 2027. Gross margin moves from a short-term turn positive to durable medium- and long-term expansion, rather than swinging sharply negative again because of inventory, project delays, and production volatility. The capital required to expand does not excessively dilute common shareholders. RPS and service revenue rise as a share, with revenue volatility converging meaningfully. Internal controls and financial-disclosure quality are fully repaired.

【Fair Buy Price】 For a balanced, conservative investor, I think the more reasonable observation/trial range is $3 to $6 per share. That range is not because the company would necessarily be cheap by then, but because only after sharply lowering "the price prepaid for an optimistic future script" does the risk/reward begin to be worth discussing.

【Target Holding Period】 If you must participate, the logic should treat it on a 5- to 10-year industrial-realization horizon; but on my current judgment, I do not recommend buying now for the sake of a 10-year hold.

【Expected Annualized Return】 Buying at the current price of $22.13, by my three scenarios, the rough annualized return over the next 10 years is:

• Conservative scenario: -15% to -20%.

• Neutral scenario: -8% to -12%.

• Optimistic scenario: -2% to +4%. These are rough results back-solved from the intrinsic-value ranges above, showing the current price is not friendly to long-term returns.

【Maximum Loss Risk】 70% to 100%. In the worst case, if order delivery falls short, expansion financing costs run high, margin recovery fails, and customer projects are delayed, while the assets lack sufficient liquidation support, the common stock could fall substantially, even close to zero.

【Metrics to Track】 The metrics most worth tracking going forward are: Quarterly new orders and period-end backlog. Whether gross margin improves consecutively and stabilizes above 30%. Whether operating cash flow and free cash flow turn durably positive. Whether RPS / service revenue rises as a share. Whether capital expenditure and the financing cadence are matched. Changes in total share count and potential dilution. Net debt and debt-refinancing terms. Top-five customer contribution and accounts-receivable concentration. Inventory turnover and new write-downs. Progress of internal-control remediation.

【Signals That Would Trigger Reassessment】 If high-quality positive operating cash flow appears for two consecutive quarters. If gross margin not only turns positive but expands stably without relying on one-off projects. If new financing comes in markedly below expectations, with limited dilution. If defense and aerospace contracts truly move from pilot/validation to volume production and repurchase. If a new material accounting restatement, internal-control failure, or frequent senior-finance-team turnover reappears.

【Final Recommendation】 Put plainly, Velo3D today looks more like a long-term call option on "whether technology and orders can ultimately convert into an economic moat" than a business you can already acquire on an Owner Earnings basis. For a balanced, conservative investor with a holding period of 10 years or more, my advice is: do not rush to buy just because the market is good, the story is strong, or recent financials have improved somewhat. First wait for it to prove it can earn money stably, then discuss whether it is worth owning; if the market will not give you the price for that wait, let it pass.

Open Questions and Information Limitations

A few pieces of information still carry basis limitations that you should watch when tracking the company. First, there may be a timing gap between the latest market cap shown by the quote terminal and the share count after the company's April 2026 offering, so "true total market cap today" may be higher than the figure the quote source shows. Second, the latest net cash after the April 2026 offering, and whether more ATM/registered capacity has been used, were not fully disclosed in the materials retrieved this time. Third, the 2023 capital-expenditure detail was not fully and separately extracted from the pages reviewed, so 2023 free cash flow can only be judged directionally. Fourth, more direct metal AM competitors such as EOS and Nikon SLM are often not independently listed companies, so comparisons of valuation and return on "pure peer comparables" are inherently limited. None of these limitations changes the current core conclusion: today this company looks more like a high-risk growth name than a low-risk buy for a conservative long-term value investor.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.